LGALS3 and early-onset autosomal dominant Alzheimer disease: Galectin-3 (Gal3) is both endogenously expressed as well as released by microglia in the brain in pathological conditions (Garcia-Revilla et al., 2022), particularly in Alzheimer’s disease (AD) (Boza-Serrano et al., 2019).